Oxygenta Pharmaceutical Ltd

NSE: SSORGS · BSE: 524636 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹48.60
Market cap: ₹179.7 Cr
Revenue (annual): ₹113.0 Cr
Net profit (annual): ₹-17.57 Cr
P/E (TTM): -15.8×Sector 43.8×
Promoter holding: 56.54%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 3 Board Meeting Date 3 Annual General Meeting 2 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

1 Oct 2026 17:58 IST BSE

Acquisition

Oxygenta Pharmaceutical Acquisition Worth ₹6.75 Cr

Oxygenta Pharmaceutical acquired land in Telangana from TGIIC for Rs. 6.75 Crore. The purchase supports business expansion and long-term strategic infrastructure needs.

Value: ₹6.75 Cr

Open announcement → Read the filing ↗